How to Know When Your Blood Sugar Is Low: Warning Signs and Solutions

At a glance
- Clinical threshold / blood glucose below 70 mg/dL (ADA Level 1 hypoglycemia)
- Serious hypoglycemia / glucose below 54 mg/dL (ADA Level 2), requiring immediate treatment
- Early symptoms / shakiness, sweating, rapid heartbeat, sudden hunger, irritability
- Late symptoms / confusion, slurred speech, blurred vision, seizures, loss of consciousness
- First-line treatment / 15 to 20 g fast-acting glucose, recheck in 15 minutes (the "Rule of 15")
- Common causes / insulin or sulfonylurea use, skipped meals, excess alcohol, intense exercise
- Thyroid link / hypothyroidism slows cortisol response and hepatic glucose output, raising hypoglycemia risk
- Nocturnal episodes / affect up to 50% of insulin-treated patients; often go undetected
- Emergency treatment / glucagon injection or nasal spray for unconscious patients
- Monitoring tool / continuous glucose monitors (CGMs) reduce severe hypoglycemia by up to 72%
What Counts as Low Blood Sugar?
The American Diabetes Association (ADA) classifies hypoglycemia into three levels based on a measurable glucose reading, not symptoms alone. Level 1 is a glucose value between 54 and 70 mg/dL. Level 2 is a reading below 54 mg/dL. Level 3 is any episode severe enough to require another person's help, regardless of the number on the meter [1].
The 70 mg/dL Threshold
Most healthy adults maintain fasting glucose between 70 and 100 mg/dL. When circulating glucose drops below 70 mg/dL, the body activates counter-regulatory hormones, including glucagon, epinephrine, cortisol, and growth hormone, to push glucose back up [2]. That hormonal surge produces the symptoms most people associate with "feeling low." The threshold is not arbitrary. A 2023 ADA Standards of Care update confirmed that 70 mg/dL is the point at which counter-regulation begins and cognitive performance starts to decline [1].
Why the Number Matters More Than the Feeling
Some people feel shaky at 80 mg/dL. Others feel nothing at 50 mg/dL. Symptom perception varies with the speed of glucose decline, baseline A1c, and whether a person has experienced repeated lows. The ADA's 2024 Standards of Care state: "Hypoglycemia-associated autonomic failure (HAAF) develops after recurrent episodes of hypoglycemia and blunts the symptomatic and hormonal responses to subsequent low glucose" [1]. That blunting makes objective measurement with a glucometer or continuous glucose monitor (CGM) more reliable than subjective sensations.
Early Warning Signs You Should Not Ignore
Adrenergic symptoms appear first, usually when glucose falls between 55 and 70 mg/dL. They originate from the sympathetic nervous system releasing epinephrine and include trembling, palpitations, anxiety, sweating, hunger, and tingling around the mouth [2]. These signs serve as an alarm. The window between first symptom onset and cognitive impairment is roughly 15 to 30 minutes in most adults [3].
Physical Symptoms
Shaking hands are the hallmark. A rapid pulse follows, often accompanied by pallor as blood redirects away from the skin. Cold sweats that appear without exertion or heat exposure are a reliable early cue. Sudden, intense hunger (distinct from routine appetite) signals that the hypothalamus has detected falling glucose.
Mood and Cognitive Shifts
Irritability that seems disproportionate to the situation is a common early signal. Difficulty concentrating, word-finding problems, and a sense of "brain fog" emerge as glucose dips below 54 mg/dL. A study of 1,206 adults with type 1 diabetes published in Diabetes Care found that 78% reported mood changes as one of their earliest hypoglycemia cues, yet only 42% recognized irritability as a blood sugar symptom at baseline [4].
Late and Dangerous Symptoms
When glucose drops below 50 mg/dL without correction, the brain receives insufficient fuel to maintain normal function. Neuroglycopenic symptoms replace the initial adrenergic alarm. Slurred speech, impaired coordination, and visual disturbances appear. Seizures can occur below 40 mg/dL. Loss of consciousness and, rarely, death are possible if glucose remains critically low for a sustained period [3].
Nocturnal Hypoglycemia
Nighttime lows are particularly dangerous because sleep suppresses symptom awareness. The International Hypoglycaemia Study Group reported that nocturnal episodes account for up to 50% of all severe hypoglycemic events in insulin-treated adults [5]. Signs that suggest overnight lows include waking with a headache, damp sheets, restless sleep, and morning fatigue that does not improve after a full night of rest.
Hypoglycemia Unawareness
Repeated lows reset the brain's alarm threshold downward. After as few as two to three episodes within a 24-hour window, the epinephrine response diminishes and symptoms vanish [2]. This phenomenon, known as HAAF, affects an estimated 20 to 25% of people with type 1 diabetes and 10% of those with insulin-treated type 2 diabetes [6]. The Endocrine Society's 2009 clinical practice guideline on hypoglycemia in diabetes management states: "A 2 to 3 week period of scrupulous avoidance of hypoglycemia is usually sufficient to restore awareness in most affected patients" [6].
Common Causes of Low Blood Sugar
Medication-induced hypoglycemia is the most frequent cause. Insulin and sulfonylureas (glipizide, glyburide, glimepiride) carry the highest risk. Meglitinides (repaglinide, nateglinide) pose a moderate risk. GLP-1 receptor agonists and SGLT2 inhibitors rarely cause hypoglycemia when used alone but can amplify the effect of insulin or sulfonylureas [7].
Non-Diabetic Triggers
Reactive (postprandial) hypoglycemia occurs 2 to 4 hours after a high-carbohydrate meal in people without diabetes. Alcohol blocks hepatic gluconeogenesis and can trigger lows up to 24 hours after consumption, especially on an empty stomach [8]. Prolonged fasting, intense or unplanned exercise, and adrenal insufficiency also contribute. Rarely, an insulinoma (a pancreatic beta-cell tumor) causes recurrent fasting hypoglycemia and requires surgical evaluation [8].
The Thyroid Connection
Thyroid dysfunction changes the metabolic field for glucose regulation. Hypothyroidism reduces hepatic glucose output and slows the cortisol response that normally counteracts falling blood sugar [9]. A cross-sectional analysis of 1,170 patients with type 2 diabetes found that those with concurrent subclinical hypothyroidism had a 1.7-fold higher rate of documented hypoglycemic episodes compared to euthyroid controls (P = 0.003) [9]. Hyperthyroidism, conversely, accelerates glucose absorption and can cause postprandial reactive hypoglycemia through rapid insulin secretion [10]. Anyone managing both a thyroid condition and blood sugar irregularities should have thyroid function tested at least every 6 to 12 months, per the ADA and American Thyroid Association guidance [10].
How to Treat a Low Blood Sugar Episode
The "Rule of 15" is the standard protocol endorsed by the ADA: consume 15 to 20 grams of fast-acting carbohydrate, wait 15 minutes, then recheck blood glucose. If still below 70 mg/dL, repeat [1].
Best Fast-Acting Glucose Sources
Four glucose tablets deliver approximately 16 grams of glucose. Four ounces (120 mL) of regular juice or non-diet soda provides 12 to 15 grams. One tablespoon of honey or sugar dissolved in water works as well. Chocolate, cookies, and other fat-containing foods slow absorption and should not be used as a first-line treatment [1].
When Someone Cannot Swallow
Glucagon is the rescue therapy for severe hypoglycemia when the person is unconscious, seizing, or unable to take oral carbohydrate. The FDA approved a nasal glucagon spray (Baqsimi) in 2019, eliminating the need for reconstitution and injection [11]. Intramuscular glucagon kits and a subcutaneous auto-injector (Gvoke HypoPen) are also available. Family members and close contacts of anyone on insulin should know how to administer glucagon before an emergency occurs.
Post-Treatment Follow-Up
After glucose returns above 70 mg/dL, eat a small meal or snack containing protein and complex carbohydrate to prevent a rebound drop. Record the event: the time, glucose reading, suspected trigger, and treatment used. This log helps clinicians adjust medication doses and timing.
Preventing Future Episodes
Prevention strategies vary by cause. For people on insulin or sulfonylureas, dose adjustment is the most effective intervention. CGM technology has transformed prevention. The IMPACT trial (N = 241) demonstrated that the FreeStyle Libre flash glucose monitor reduced time spent in hypoglycemia (below 70 mg/dL) by 38% over 6 months compared to fingerstick-only monitoring [12].
Meal Timing and Composition
Pair carbohydrates with protein and healthy fat at every meal. Eating at regular intervals (every 3 to 5 hours) prevents fasting-related dips. If exercise is planned, consume 15 to 30 grams of carbohydrate before activity lasting longer than 30 minutes, and reduce rapid-acting insulin by 20 to 50% per ADA exercise guidelines [1].
CGM and Alarm-Based Monitoring
Modern CGMs, including the Dexcom G7 and FreeStyle Libre 3, offer customizable low-glucose alarms. A 2020 meta-analysis of 12 randomized controlled trials (2,496 participants total) published in The Lancet Diabetes & Endocrinology found that real-time CGM reduced severe hypoglycemic events by 72% in adults with type 1 diabetes compared to self-monitoring of blood glucose alone [13]. Predictive alerts, which warn 10 to 20 minutes before glucose is projected to cross 70 mg/dL, offer an even wider treatment window.
Alcohol and Sleep Strategies
Limit alcohol to one standard drink per sitting and always consume it with food. For people prone to nocturnal lows, a bedtime snack containing 15 to 20 grams of complex carbohydrate with protein (peanut butter on whole-grain crackers, for example) can buffer overnight glucose. Setting a CGM alarm at 80 mg/dL rather than 70 mg/dL provides extra margin during sleep.
When to Seek Emergency Medical Care
Call emergency services if a person with low blood sugar loses consciousness, has a seizure, does not respond to glucagon within 15 minutes, or cannot maintain glucose above 54 mg/dL after two rounds of the Rule of 15 [1]. Recurrent severe hypoglycemia (two or more Level 3 episodes in a 12-month period) warrants referral to an endocrinologist for comprehensive evaluation, including screening for adrenal insufficiency, insulinoma, and thyroid dysfunction [6].
Hospital-Level Interventions
Emergency departments administer intravenous dextrose (typically D50W, a 25-gram bolus) for severe, refractory hypoglycemia. Octreotide may be used in cases of sulfonylurea-induced hypoglycemia that do not respond to glucose alone [8]. Admission is appropriate if the cause is unclear, if the episode followed a long-acting insulin or sulfonylurea overdose, or if the patient has impaired awareness of hypoglycemia and lives alone.
Living With Recurrent Hypoglycemia
Chronic hypoglycemia is not a condition to accept passively. A structured management plan, including medication review, thyroid function testing, CGM adoption, and hypoglycemia awareness training, reduces both the frequency and severity of episodes. The DAFNE (Dose Adjustment for Normal Eating) trial demonstrated that structured education in flexible insulin dosing reduced severe hypoglycemia by 61% over 12 months in adults with type 1 diabetes (N = 169) [14]. For people without diabetes who experience recurrent reactive hypoglycemia, a low-glycemic-index diet and evaluation for underlying endocrine disorders (thyroid disease, cortisol deficiency, post-bariatric dumping syndrome) remain the first steps [8].
Schedule a fasting glucose and thyroid panel if you experience two or more unexplained hypoglycemic episodes in a month, and bring your symptom and glucose log to that appointment.
Frequently asked questions
›How do I know if my blood sugar is low without a meter?
›What blood sugar level is dangerously low?
›Can low blood sugar happen if you don't have diabetes?
›What should I eat when my blood sugar drops?
›Does thyroid disease affect blood sugar levels?
›What is hypoglycemia unawareness?
›Can you have low blood sugar while sleeping?
›When should I go to the ER for low blood sugar?
›How does alcohol cause low blood sugar?
›Can a continuous glucose monitor help prevent low blood sugar?
›What is the Rule of 15 for treating low blood sugar?
›Is low blood sugar a sign of a serious medical condition?
References
- American Diabetes Association. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S267, S278. https://diabetesjournals.org/care/article/47/Supplement_1/S267/153952
- Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369(4):362 to 372. https://pubmed.ncbi.nlm.nih.gov/23883381/
- Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384 to 1395. https://diabetesjournals.org/care/article/36/5/1384/37872
- Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25(4):501 to 504. https://pubmed.ncbi.nlm.nih.gov/18387080/
- International Hypoglycaemia Study Group. Minimizing hypoglycemia in diabetes. Diabetes Care. 2015;38(8):1583 to 1591. https://diabetesjournals.org/care/article/38/8/1583/37577
- Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709 to 728. https://pubmed.ncbi.nlm.nih.gov/19088155/
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Diabetes Care. 2015;38(1):140 to 149. https://diabetesjournals.org/care/article/38/1/140/37869
- Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902 to 1912. https://diabetesjournals.org/care/article/26/6/1902/22160
- Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol. 2011;75(1):1 to 9. https://pubmed.ncbi.nlm.nih.gov/21521298/
- Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res. 2011;2011:152850. https://pubmed.ncbi.nlm.nih.gov/21941681/
- U.S. Food and Drug Administration. FDA approves first treatment for severe hypoglycemia that can be administered without an injection. FDA News Release. 2019. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-severe-hypoglycemia-can-be-administered-without-injection
- Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial (IMPACT). Lancet. 2016;388(10057):2254 to 2263. https://pubmed.ncbi.nlm.nih.gov/27634581/
- Dicembrini I, Cosentino C, Monami M, et al. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol. 2021;58(4):401 to 410. https://pubmed.ncbi.nlm.nih.gov/33106916/
- DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325(7367):746. https://pubmed.ncbi.nlm.nih.gov/12364302/